Research Highlight | Published:

SARCOMA

Desmoid tumours stalled by sorafenib

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Gounder, M. M. et al. Sorafenib for advanced and refractory desmoid tumors. N. Engl. J. Med. 379, 2417–2428 (2018)

    Download references

    Author information

    Correspondence to Katharine H. Wrighton.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark